Tacere Scores Seed Financing
San Jose-based Tacere Therapeutics has received an undisclosed amount of seed financing, the firm said today. The funding came from Hokkaido Venture Capital. Tacere is developing treatments for serious infectious disease, and is initially focused on the treatment of Hepatitis C.
posted on Thursday, October 12, 2006 (Link to more information)
Related companies:
Tacere Therapeutics
Related stories:
> Innovalight Scores $5M
> Surf Canyon Gets Seed
> Spiro Scores $1.5M In Seed For Sales App
> vChatter Scores $350K In Seed Funds
> EggCartel Scores $1M In Seed Funding
silicontap.com Home